drugset / Trial / NCT06332053
A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a single-center, open-lable and fixed sequence test conducted in healthy subjects to evaluate the pharmacokinetic effects of Itraconazole and Rifampicin on a single dose of SY-5007 Oral administration. It is planned to enroll 28 healthy subjects and assign them to two parallel test groups, Group A (SY-5007 combined with Itraconazole) and Group B (SY-5007 combined with Rifampicin).
Timeline
- Start
- 2024-04-01
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 200 mg | Oral |
| Subject | Rifampicin | Small molecule | 600 mg | Oral |
| Subject | SY-5007 | Unknown | 80 mg | Oral |
| Subject | SY-5007 | Unknown | 160 mg | Oral |
Indications
No indication recorded.